Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 72789-434

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 72789-434). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789434 Label (72789434)

Norgestimate and Ethinyl Estradiol 0.250mg/0.035mg 28 tablets kit label by PD-Rx Pharmaceuticals, Inc. The label includes the product NDC 72789-434-79, batch lot 10005476, and expiration date 04/2025. Usage instructions and warnings about keeping out of reach of children are displayed, along with reorder number 111613 and manufacturer contact information.*

FDA Label Image

Norgestimate Structural Formula (Image 01)

Chemical structure of Norgestimate, an active ingredient in Norgestimate and Ethinyl Estradiol products. The structure shows the steroidal backbone with attached functional groups, including acetoxy and enyne moieties.*

FDA Label Image

Ethinyl Estradiol Structural Formula (Image 02)

Chemical structure of Ethinyl Estradiol, a synthetic estrogen used in combination hormonal contraceptives. The diagram displays the steroid backbone with hydroxyl groups and characteristic ethynyl substitution.*

FDA Label Image

Fewer-more Pregnancies Image (Image 03)

A vertical diagram illustrating pregnancy rates per 100 women in one year associated with different contraceptive methods. The scale ranges from fewer than 1 pregnancy at the top to 85 or more at the bottom. Methods listed from most to least effective include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, behavioral methods (abstinence during fertile days), spermicide, withdrawal, and no birth control.*

FDA Label Image

Blister Image (Image 04)

Sprintec oral contraceptive tablet blister card, each tablet contains norgestimate and ethinyl estradiol 0.250 mg/0.035 mg. The card is a 28-day kit with four rows of pills labeled by week and day (Sunday to Saturday). The first three weeks contain gray pills and the fourth week contains white pills. The card instructs to take all colored pills before any white pills. Label includes storage instructions at 20° to 25°C (68° to 77°F).*

FDA Label Image

Blister Image (Image 05)

Blister card packaging label for Sprintec, containing norgestimate and ethinyl estradiol tablets USP 0.250 mg / 0.035 mg. The kit provides a 28-day supply with pills arranged in four rows by day of week and week number. The first three rows have colored pills and the fourth row contains white pills. Instructions indicate to take all colored pills before any white pills. The labeler is PD-Rx Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.